Yali Friedman
Yali Friedman, PhD is publisher of DrugPatentWatch.com.
Yali is also publisher of the Journal of Commercial Biotechnology and author of Building Biotechnology, which is used as a course text in dozens of biotechnology programs. He was also named one of the 100 most influential people in biotechnology by Scientific American.
Yali has strong exposure to leading issues in international biotechnology. He is editor of the Scientific American worldVIEW scorecard, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC, in Europe, and throughout Asia.
He can be reached at yali@DrugPatentWatch.com and on LinkedIn
Articles by Yali Friedman:
My Favourite Tipples from a business intelligence publisher
Wednesday, 7th June 2017
My Favourite Tipples are shared by Yali Friedman, publisher of DrugPatentWatch.com, a global intelligence database. He shares his favourite online tools for better international communication.
Community session
11th December 2024
2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024
How are information managers getting involved with AI? Navigating privacy, ethics, and intellectual property
- 2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024 - All recent Jinfo Subscription content
31st October 2024 - End-user training best practice research
24th October 2024
- Jinfo Community session (TBC) (Community) 23rd January 2025
- Clinic on contracting for AI (Community) 11th December 2024
- Discussing news and AI strategies with the Financial Times (Community) 21st November 2024